Fulcrum Therapeutics Inc. (FULC)
Market Closed
15 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 51
+0.06
+1.7391%
$
186.68M Market Cap
- P/E Ratio
- Div Yield
3.17M Volume
-1.75 Eps
$ 3.45
Previous Close 
Want to track FULC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Fulcrum Therapeutics Inc. (FULC) Statistics
Valuation metrics
Market Cap 186.68M
Enterprise value 142.29M
Trailing P/E (ttm) -3.45
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.79
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.9
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.34M
Average volume (90 days) 1.54M
Price summary
52-Week low 2.83
52-Week high 15.74
Beta -
50-Day moving average 6.64
200-Day moving average 9.09
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.22%
Return on equity -0.28%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.37
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 34.33%
Book value per share (mrq) 4.37
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
